We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

REE:NASDAQREE Automotive Ltd. Analysis

Data as of 2026-07-16 - not real-time

$0.08

Latest Price

9/10Risk

Risk Level: High

Executive Summary

REE Automotive is trading at $0.0769, barely above its 30‑day support of $0.067 and far below its 20‑day SMA of 0.188, 50‑day SMA of 0.329 and 200‑day SMA of 0.636, confirming a strong bearish price structure. The RSI 14 sits at 15.4, indicating extreme oversold conditions, while the MACD line remains under the signal line with a negative histogram, reinforcing the bearish momentum. Volume has been increasing, yet the stock exhibits a staggering 310% 30‑day volatility and a historic max drawdown of ‑94.5%, underscoring extreme price instability. Compounding the technical weakness, Nasdaq has issued a delisting notice for failure to meet Listing Rule 5550(a)(2), placing the share’s continued market presence in jeopardy.
Fundamentally, REE reports only $1.30 M in revenue despite a 45% growth rate, but its gross margin is a negative ‑26% and operating margin a negative ‑8.7%, with no earnings and a cash burn of $68.7 M. The balance sheet shows $19.2 M of debt versus $14.2 M of cash, yielding a debt‑to‑equity ratio above 283, and both ROE and ROA are deeply negative. Valuation multiples are low (P/B < 0.33, P/S ~1.73) but are outweighed by the company’s financial distress, lack of dividend, and regulatory risk, making the stock a high‑risk speculative play.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • Nasdaq delisting notice
  • Bearish technicals (price below all SMAs, RSI 15)
  • Negative earnings and cash flow

Medium Term

1–3 years
Cautious
Model confidence: 7/10

Key Factors

  • Continued operating losses
  • High debt load relative to equity
  • Elevated volatility and drawdown risk

Long Term

> 3 years
Cautious
Model confidence: 6/10

Key Factors

  • Unclear path to profitability
  • Potential delisting and loss of market access
  • Sector cyclicality without a clear competitive moat

Key Metrics & Analysis

Financial Health

Revenue Growth4537.50%
P/E Ratio-0.0
ROE-373.57%
ROA-47.23%
Debt/Equity283.87
P/B Ratio0.3
Op. Cash Flow$-68710000
Free Cash Flow$-32616000

Technical Analysis

TrendBearish
RSI15.4
Support$0.07
Resistance$0.57
MA 20$0.19
MA 50$0.33
MA 200$0.64
MACDBearish
VolumeIncreasing
Fear & Greed Index92.7

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta0.67
Volatility310.68%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.